StockData
Omega Healthcare Investors Inc logo

Omega Healthcare Investors Inc (OHI) stock analysis

OHINYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/301% above fair value
$47.03−1.09 (-2.27%)

Close on Nov 12, 2026Market cap $14.25BP/E 19.2Yield 5.70%

StockData Score

Prices as of Nov 11, 2026How the score works

Value2Growth3Performance2Health0Dividend3

Mixed10 of 30 checks passed

Omega Healthcare Investors passes 10 of the 30 checks behind our score; 12 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
2/6
Growth
3/6
Past performance
2/6
Financial health
0/6
Dividend
3/6

What stands out

  • Revenue growing 10%+ a year

    Revenue grew 10.7% a year over the last three fiscal years.

  • P/E below its 5-year median

    Omega Healthcare Investors's P/E of 19.6 is below its own 5-year median of 24.4.

  • P/E below the industry

    Omega Healthcare Investors's P/E of 19.6 is below the Miscellaneous Investing median of 26.3.

  • Guidance raised

    Omega Healthcare Investors raised its 2026 Adjusted FFO outlook on Jul 29, 2026.

What to watch

  • Margin of safety under 20%

    The price is 0.8% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $48.12 is above our fair value estimate of $47.72.

  • EPS growing under 10% a year

    Diluted EPS grew 2.5% a year over the last three fiscal years.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.87; above 3 is the safe zone and below 1.8 the distress zone.

Valuation2/6

  • P/E below its 5-year median

    Omega Healthcare Investors's P/E of 19.6 is below its own 5-year median of 24.4.

  • P/E below the industry

    Omega Healthcare Investors's P/E of 19.6 is below the Miscellaneous Investing median of 26.3.

  • EV/EBITDA above its 5-year median

    Omega Healthcare Investors's EV/EBITDA of 11.1 is above its 5-year median of 9.6.

  • P/B above the industry

    Omega Healthcare Investors's price-to-book of 2.65 is above the Miscellaneous Investing median of 1.20.

  • Trading above fair value

    The share price of $48.12 is above our fair value estimate of $47.72.

  • Margin of safety under 20%

    The price is 0.8% above fair value, so there is no margin of safety.

Growth3/6

  • Revenue growing 10%+ a year

    Revenue grew 10.7% a year over the last three fiscal years.

  • EPS growing under 10% a year

    Diluted EPS grew 2.5% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 14.0% over the last twelve months; the Miscellaneous Investing median is 4.6%.

  • Guidance raised

    Omega Healthcare Investors raised its 2026 Adjusted FFO outlook on Jul 29, 2026.

  • Gross margin trend

    This company does not report gross profit.

Past performance2/6

  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity above the industry

    Omega Healthcare Investors's return on equity of 14.5% is above the Miscellaneous Investing median of 3.1%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin against its history

    Needs five years of revenue and net income.

  • Net margin above the industry

    Omega Healthcare Investors's net margin of 58.1% is above the Miscellaneous Investing median of 10.3%.

Financial health0/6

  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt coverage

    Needs operating cash flow.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term liquidity

    The balance sheet is not split into current and non-current items.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.87; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6

  • Pays a dividend

    Omega Healthcare Investors paid dividends worth 4.2% of the share price over the last twelve months.

  • Yield below Treasuries

    The 4.2% yield is below the 4.4% on a 1-year Treasury.

  • Yield in the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Omega Healthcare Investors yields 4.2%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Not covered by earnings

    Dividends take 106% of net income, leaving little room.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Fair value

How we estimate it

Our estimate per share

$47.72

The share price is 1% above this estimate.

20%+ below
Near fair value
20%+ above
$48.12Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E25.4×24.4×26.3×$62.1140%
EV/EBITDA9.5×9.6×9.5×$42.1535%
P/B1.7×2.2×1.2×$30.9810%
Earnings power7.4% cost of equity––$33.4715%
Fair value$47.72100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 24.4
  • Miscellaneous Investing median 26.3

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$96.24M
Value traded per 1% price move
$87.07M

Downside

Low risk

Typical loss in a bad month
8.8%
Volatility (annualized)
21%
Sharpe ratio, 1 year
0.24
Beta to the S&P 500 (5Y)
0.26

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Operating margin

–

Net margin

49.6%

See a number that looks wrong?